van Kleef E M, Smits J F, De Mey J G, Cleutjens J P, Lombardi D M, Schwartz S M, Daemen M J
Department of Pathology, University of Limburg, Maastricht, The Netherlands.
Circ Res. 1992 Jun;70(6):1122-7. doi: 10.1161/01.res.70.6.1122.
We explored effects of alpha 1-adrenoreceptor blockade with prazosin on the increased vascular smooth muscle cell (SMC) DNA synthesis induced by angiotensin II (Ang II) in rats. Ang II was infused with or without prazosin or its solvent. Observations were compared with those in rats receiving saline or solvent. In group A, Ang II was infused for 2 weeks by subcutaneously implanted osmotic minipumps at a rate of 35 ng/100 g per minute. Group B received Ang II together with the alpha 1-adrenoreceptor antagonist prazosin (0.35 micrograms/100 g per minute). Group C received Ang II and 50% dimethyl sulfoxide (DMSO), the solvent of prazosin; group D received 50% DMSO; and group E received 0.9% NaCl (Ang II vehicle). All animals were infused with 5-bromo-2'-deoxyuridine for 2 weeks via separate minipumps to measure DNA synthesis. Ang II significantly increased the fraction of DNA synthesizing SMCs in the media of the thoracic aorta from 0.4 +/- 0.1% (mean +/- SD) in group E (n = 6) to 10.8 +/- 7.0% in group A (n = 8). Addition of prazosin to Ang II reduced the labeling fraction of SMCs to 3.0 +/- 2.2% (group B, n = 9). The remaining SMC DNA synthesis in the prazosin-treated group was probably due to the effects of the solvent of prazosin, i.e., 50% DMSO, since infusion of 50% DMSO alone increased the labeling fraction to 4.1 +/- 2.0% (group D, n = 6).(ABSTRACT TRUNCATED AT 250 WORDS)
我们研究了哌唑嗪对血管紧张素II(Ang II)诱导的大鼠血管平滑肌细胞(SMC)DNA合成增加的α1 - 肾上腺素能受体阻滞作用。在有或没有哌唑嗪或其溶剂的情况下输注Ang II。将观察结果与接受生理盐水或溶剂的大鼠进行比较。在A组中,通过皮下植入渗透微型泵以每分钟35 ng/100 g的速率输注Ang II 2周。B组接受Ang II与α1 - 肾上腺素能受体拮抗剂哌唑嗪(每分钟0.35微克/100 g)。C组接受Ang II和50%二甲基亚砜(DMSO),即哌唑嗪的溶剂;D组接受50% DMSO;E组接受0.9% NaCl(Ang II载体)。所有动物通过单独的微型泵输注5 - 溴 - 2'-脱氧尿苷2周以测量DNA合成。Ang II显著增加了胸主动脉中层DNA合成SMC的比例,从E组(n = 6)的0.4±0.1%(平均值±标准差)增加到A组(n = 8)的10.8±7.0%。在Ang II中加入哌唑嗪可将SMC的标记比例降低至3.0±2.2%(B组,n = 9)。哌唑嗪治疗组中剩余的SMC DNA合成可能归因于哌唑嗪的溶剂,即50% DMSO的作用,因为单独输注50% DMSO可将标记比例提高到4.1±2.0%(D组,n = 6)。(摘要截断于250字)